Delivery Order SPE2DB22D3301-SPE2DB24FY3VG
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,209.55 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of PREVNAR 13 syringes, a pneumococcal vaccine, with a performance period through March 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $2,274.80 to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a vaccine product, with a completion date of February 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $16,275.33 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of PREVNAR 13 syringes, with a performance period through March 26, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to...
- This is a $99,485.39 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREVNAR 13 syringes, a pneumococcal conjugate vaccine, to support federal healthcare programs. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This is a $13,593.83 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PREVNAR 13 SYRINGE 0.5ML, a pneumococcal conjugate vaccine, with a period of performance through March 5, 2024. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order worth $12,693.15 by the Defense Logistics Agency (DLA) to provide PREVNAR 13 syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a subsidiary of AmerisourceBergen Corporation, a major pharmaceutical distribution company. The $4,231.02 firm fixed-price contract is for the provision of PREVNAR 13 syringes, a pneumococcal vaccine. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit company Amerisourcebergen Corporation, to provide PREVNAR 13 vaccines. The order has a potential value of $6,923.72 and a completion date of October 19, 2023. Amerisourcebergen Drug Corp is the prime contractor on this order and also holds a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31,...
- The U.S. government, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $2,354.27 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply PREVNAR 13 0.5 ML syringes. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp as a single award. The IDC serves as the primary vehicle for Amerisourcebergen to provide...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PREVNAR 13 syringes, a vaccine product, with a ceiling value of $8,394.54 and an ultimate completion date of April 18, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY3VGDelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $32,128.24, is for the provision of PREVNAR 13 syringes, a pneumococcal vaccine product, to support U.S. military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense. This specific delivery order falls under the scope of that larger IDC. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp is also the prime contractor on other federal contracts with agencies such as the Department of Justice Federal Bureau of Investigation to provide medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.1k | 4/2/24 |